CRWD Research Note — Demand Runs Ahead
CrowdStrike’s cRPO and retention improved, but valuation makes the August 26 margin and net-new ARR evidence the next decisive test for the recovery.
CrowdStrike’s cRPO and retention improved, but valuation makes the August 26 margin and net-new ARR evidence the next decisive test for the recovery.
CrowdStrike’s forward demand is improving, but a 44.3-times sales multiple makes the August 26 margin and net-new ARR evidence decisive for the thesis.